RNF170 mutation causes autosomal dominant sensory ataxia with variable pyramidal involvement
Background Although hereditary ataxias are a group of clinically and genetically heterogeneous disorders, specific clinical clues can sometimes incriminate certain genes. This can trigger genetic testing in sporadic patients or prompt dissecting certain genes more thoroughly when initial genetic tes...
Gespeichert in:
Veröffentlicht in: | European journal of neurology 2022-01, Vol.29 (1), p.345-349 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 349 |
---|---|
container_issue | 1 |
container_start_page | 345 |
container_title | European journal of neurology |
container_volume | 29 |
creator | Van Daele, Sien H. Moisse, Matthieu Race, Valérie Van Eesbeeck, Amélie Keldermans, Liesbeth Vermeer, Sascha Van Esch, Hilde Claeys, Kristl G. Van Damme, Philip |
description | Background
Although hereditary ataxias are a group of clinically and genetically heterogeneous disorders, specific clinical clues can sometimes incriminate certain genes. This can trigger genetic testing in sporadic patients or prompt dissecting certain genes more thoroughly when initial genetic testing is negative. Also for the assembly of gene panels and interpretation of the results, genotype−phenotype correlations remain important to establish.
Methods
We clinically evaluated a Belgian family with autosomal dominant inherited sensory ataxia and variable pyramidal involvement and performed targeted clinical exome sequencing. Secondly, we retrospectively screened sequencing data of an in‐house cohort of 404 patients with neuromuscular disorders for variants in the identified gene RNF170.
Results
All affected family members showed sensory ataxia on examination. Pyramidal involvement, and sometimes slow‐pursuit abnormalities and/or a sensory neuropathy, were more variable findings. We identified the heterozygous variant p.Arg199Cys in RNF170 in all three affected siblings of our family. We did not find additional pathogenic variants in RNF170 in our in‐house neuromuscular cohort.
Conclusions
We confirm the heterozygous variant p.Arg199Cys in RNF170 in a Belgian family with autosomal dominant sensory ataxia and variable pyramidal involvement. This constitutes a rare but clinically recognizable phenotype that warrants testing of RNF170. Unlike the distinctive bi‐allelic loss of function variants in RNF170 associated with hereditary spastic paraplegia (HSP), the p.Arg199Cys variant is the only one reported in sensory ataxia. It is important for neurologists to be aware of this characteristic phenotype and to include this gene in gene panels for ataxia and HSP.
Patients with the heterozygous variant p.Arg199Cys in RNF170 display a characteristic phenotype of autosomal dominant sensory ataxia with variable pyramidal involvement and sometimes slow‐pursuit abnormalities and/or a sensory neuropathy. Unlike the distinctive bi‐allelic loss of function variants in RNF170 associated with hereditary spastic paraplegia (HSP), the p.Arg199Cys variant is the only one reported in sensory ataxia. It is important for neurologists to be aware of this characteristic phenotype and to include this gene in gene panels for ataxia and HSP. |
doi_str_mv | 10.1111/ene.15091 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9290118</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2607544822</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4431-ca8a1e74f56cf420579d9ab1b04245df4278d8ea7bc7e43eea525d568b3af1533</originalsourceid><addsrcrecordid>eNp1kV1rFTEQhoNY7Ide-Ack4I292DaTj_24EaScaqFUEL0TwuzurE3ZTY7J7qnn35t6aqkFc5MweXhmkpex1yBOIK9T8nQCRjTwjB2ALusClILn-awMFAYE7LPDlG6EELKS4gXbV1qXTSnhgH3_cnUOleDTMuPsgucdLokSx2UOKUw48j5MzqOfeSKfQtxynPGXQ37r5mu-weiwHYmvtxEn12fe-U0YNzSRn1-yvQHHRK_u9yP27Xz19exTcfn548XZh8ui01pB0WGNQJUeTNkNWgpTNX2DLbRCS236XKrqvias2q4irYjQSNObsm4VDmCUOmLvd9710k7Ud7l1xNGuo5swbm1AZ_-98e7a_ggb28hGANRZ8O5eEMPPhdJsJ5c6Gkf0FJZkZW5W5v8FmdG3T9CbsESfn2dlKSqjdS3vqOMd1cWQUqThYRgQ9i4zmzOzfzLL7JvH0z-Qf0PKwOkOuHUjbf9vsqur1U75G7CbofM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2607544822</pqid></control><display><type>article</type><title>RNF170 mutation causes autosomal dominant sensory ataxia with variable pyramidal involvement</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Van Daele, Sien H. ; Moisse, Matthieu ; Race, Valérie ; Van Eesbeeck, Amélie ; Keldermans, Liesbeth ; Vermeer, Sascha ; Van Esch, Hilde ; Claeys, Kristl G. ; Van Damme, Philip</creator><creatorcontrib>Van Daele, Sien H. ; Moisse, Matthieu ; Race, Valérie ; Van Eesbeeck, Amélie ; Keldermans, Liesbeth ; Vermeer, Sascha ; Van Esch, Hilde ; Claeys, Kristl G. ; Van Damme, Philip</creatorcontrib><description>Background
Although hereditary ataxias are a group of clinically and genetically heterogeneous disorders, specific clinical clues can sometimes incriminate certain genes. This can trigger genetic testing in sporadic patients or prompt dissecting certain genes more thoroughly when initial genetic testing is negative. Also for the assembly of gene panels and interpretation of the results, genotype−phenotype correlations remain important to establish.
Methods
We clinically evaluated a Belgian family with autosomal dominant inherited sensory ataxia and variable pyramidal involvement and performed targeted clinical exome sequencing. Secondly, we retrospectively screened sequencing data of an in‐house cohort of 404 patients with neuromuscular disorders for variants in the identified gene RNF170.
Results
All affected family members showed sensory ataxia on examination. Pyramidal involvement, and sometimes slow‐pursuit abnormalities and/or a sensory neuropathy, were more variable findings. We identified the heterozygous variant p.Arg199Cys in RNF170 in all three affected siblings of our family. We did not find additional pathogenic variants in RNF170 in our in‐house neuromuscular cohort.
Conclusions
We confirm the heterozygous variant p.Arg199Cys in RNF170 in a Belgian family with autosomal dominant sensory ataxia and variable pyramidal involvement. This constitutes a rare but clinically recognizable phenotype that warrants testing of RNF170. Unlike the distinctive bi‐allelic loss of function variants in RNF170 associated with hereditary spastic paraplegia (HSP), the p.Arg199Cys variant is the only one reported in sensory ataxia. It is important for neurologists to be aware of this characteristic phenotype and to include this gene in gene panels for ataxia and HSP.
Patients with the heterozygous variant p.Arg199Cys in RNF170 display a characteristic phenotype of autosomal dominant sensory ataxia with variable pyramidal involvement and sometimes slow‐pursuit abnormalities and/or a sensory neuropathy. Unlike the distinctive bi‐allelic loss of function variants in RNF170 associated with hereditary spastic paraplegia (HSP), the p.Arg199Cys variant is the only one reported in sensory ataxia. It is important for neurologists to be aware of this characteristic phenotype and to include this gene in gene panels for ataxia and HSP.</description><identifier>ISSN: 1351-5101</identifier><identifier>EISSN: 1468-1331</identifier><identifier>DOI: 10.1111/ene.15091</identifier><identifier>PMID: 34469621</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>Abnormalities ; Ataxia ; Ataxia - genetics ; case study ; Disorders ; Genes ; Genetic screening ; Genotype & phenotype ; Genotypes ; genotype−phenotype correlation ; Hereditary spastic paraplegia ; Humans ; medical genetics ; Mutation ; Mutation - genetics ; Neurogtics ; Neuromuscular diseases ; Neuropathy ; Panels ; Paraplegics ; Patients ; Pedigree ; Phenotype ; Phenotypes ; Retrospective Studies ; sensory ataxia ; Short Communication ; spastic paraparesis ; Spastic Paraplegia, Hereditary - genetics ; Spasticity ; Ubiquitin-Protein Ligases - genetics</subject><ispartof>European journal of neurology, 2022-01, Vol.29 (1), p.345-349</ispartof><rights>2021 The Authors. published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.</rights><rights>2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4431-ca8a1e74f56cf420579d9ab1b04245df4278d8ea7bc7e43eea525d568b3af1533</citedby><cites>FETCH-LOGICAL-c4431-ca8a1e74f56cf420579d9ab1b04245df4278d8ea7bc7e43eea525d568b3af1533</cites><orcidid>0000-0002-3005-3619 ; 0000-0002-4010-2357 ; 0000-0001-9937-443X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fene.15091$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fene.15091$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,778,782,883,1414,27907,27908,45557,45558</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34469621$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Van Daele, Sien H.</creatorcontrib><creatorcontrib>Moisse, Matthieu</creatorcontrib><creatorcontrib>Race, Valérie</creatorcontrib><creatorcontrib>Van Eesbeeck, Amélie</creatorcontrib><creatorcontrib>Keldermans, Liesbeth</creatorcontrib><creatorcontrib>Vermeer, Sascha</creatorcontrib><creatorcontrib>Van Esch, Hilde</creatorcontrib><creatorcontrib>Claeys, Kristl G.</creatorcontrib><creatorcontrib>Van Damme, Philip</creatorcontrib><title>RNF170 mutation causes autosomal dominant sensory ataxia with variable pyramidal involvement</title><title>European journal of neurology</title><addtitle>Eur J Neurol</addtitle><description>Background
Although hereditary ataxias are a group of clinically and genetically heterogeneous disorders, specific clinical clues can sometimes incriminate certain genes. This can trigger genetic testing in sporadic patients or prompt dissecting certain genes more thoroughly when initial genetic testing is negative. Also for the assembly of gene panels and interpretation of the results, genotype−phenotype correlations remain important to establish.
Methods
We clinically evaluated a Belgian family with autosomal dominant inherited sensory ataxia and variable pyramidal involvement and performed targeted clinical exome sequencing. Secondly, we retrospectively screened sequencing data of an in‐house cohort of 404 patients with neuromuscular disorders for variants in the identified gene RNF170.
Results
All affected family members showed sensory ataxia on examination. Pyramidal involvement, and sometimes slow‐pursuit abnormalities and/or a sensory neuropathy, were more variable findings. We identified the heterozygous variant p.Arg199Cys in RNF170 in all three affected siblings of our family. We did not find additional pathogenic variants in RNF170 in our in‐house neuromuscular cohort.
Conclusions
We confirm the heterozygous variant p.Arg199Cys in RNF170 in a Belgian family with autosomal dominant sensory ataxia and variable pyramidal involvement. This constitutes a rare but clinically recognizable phenotype that warrants testing of RNF170. Unlike the distinctive bi‐allelic loss of function variants in RNF170 associated with hereditary spastic paraplegia (HSP), the p.Arg199Cys variant is the only one reported in sensory ataxia. It is important for neurologists to be aware of this characteristic phenotype and to include this gene in gene panels for ataxia and HSP.
Patients with the heterozygous variant p.Arg199Cys in RNF170 display a characteristic phenotype of autosomal dominant sensory ataxia with variable pyramidal involvement and sometimes slow‐pursuit abnormalities and/or a sensory neuropathy. Unlike the distinctive bi‐allelic loss of function variants in RNF170 associated with hereditary spastic paraplegia (HSP), the p.Arg199Cys variant is the only one reported in sensory ataxia. It is important for neurologists to be aware of this characteristic phenotype and to include this gene in gene panels for ataxia and HSP.</description><subject>Abnormalities</subject><subject>Ataxia</subject><subject>Ataxia - genetics</subject><subject>case study</subject><subject>Disorders</subject><subject>Genes</subject><subject>Genetic screening</subject><subject>Genotype & phenotype</subject><subject>Genotypes</subject><subject>genotype−phenotype correlation</subject><subject>Hereditary spastic paraplegia</subject><subject>Humans</subject><subject>medical genetics</subject><subject>Mutation</subject><subject>Mutation - genetics</subject><subject>Neurogtics</subject><subject>Neuromuscular diseases</subject><subject>Neuropathy</subject><subject>Panels</subject><subject>Paraplegics</subject><subject>Patients</subject><subject>Pedigree</subject><subject>Phenotype</subject><subject>Phenotypes</subject><subject>Retrospective Studies</subject><subject>sensory ataxia</subject><subject>Short Communication</subject><subject>spastic paraparesis</subject><subject>Spastic Paraplegia, Hereditary - genetics</subject><subject>Spasticity</subject><subject>Ubiquitin-Protein Ligases - genetics</subject><issn>1351-5101</issn><issn>1468-1331</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kV1rFTEQhoNY7Ide-Ack4I292DaTj_24EaScaqFUEL0TwuzurE3ZTY7J7qnn35t6aqkFc5MweXhmkpex1yBOIK9T8nQCRjTwjB2ALusClILn-awMFAYE7LPDlG6EELKS4gXbV1qXTSnhgH3_cnUOleDTMuPsgucdLokSx2UOKUw48j5MzqOfeSKfQtxynPGXQ37r5mu-weiwHYmvtxEn12fe-U0YNzSRn1-yvQHHRK_u9yP27Xz19exTcfn548XZh8ui01pB0WGNQJUeTNkNWgpTNX2DLbRCS236XKrqvias2q4irYjQSNObsm4VDmCUOmLvd9710k7Ud7l1xNGuo5swbm1AZ_-98e7a_ggb28hGANRZ8O5eEMPPhdJsJ5c6Gkf0FJZkZW5W5v8FmdG3T9CbsESfn2dlKSqjdS3vqOMd1cWQUqThYRgQ9i4zmzOzfzLL7JvH0z-Qf0PKwOkOuHUjbf9vsqur1U75G7CbofM</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Van Daele, Sien H.</creator><creator>Moisse, Matthieu</creator><creator>Race, Valérie</creator><creator>Van Eesbeeck, Amélie</creator><creator>Keldermans, Liesbeth</creator><creator>Vermeer, Sascha</creator><creator>Van Esch, Hilde</creator><creator>Claeys, Kristl G.</creator><creator>Van Damme, Philip</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3005-3619</orcidid><orcidid>https://orcid.org/0000-0002-4010-2357</orcidid><orcidid>https://orcid.org/0000-0001-9937-443X</orcidid></search><sort><creationdate>202201</creationdate><title>RNF170 mutation causes autosomal dominant sensory ataxia with variable pyramidal involvement</title><author>Van Daele, Sien H. ; Moisse, Matthieu ; Race, Valérie ; Van Eesbeeck, Amélie ; Keldermans, Liesbeth ; Vermeer, Sascha ; Van Esch, Hilde ; Claeys, Kristl G. ; Van Damme, Philip</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4431-ca8a1e74f56cf420579d9ab1b04245df4278d8ea7bc7e43eea525d568b3af1533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Abnormalities</topic><topic>Ataxia</topic><topic>Ataxia - genetics</topic><topic>case study</topic><topic>Disorders</topic><topic>Genes</topic><topic>Genetic screening</topic><topic>Genotype & phenotype</topic><topic>Genotypes</topic><topic>genotype−phenotype correlation</topic><topic>Hereditary spastic paraplegia</topic><topic>Humans</topic><topic>medical genetics</topic><topic>Mutation</topic><topic>Mutation - genetics</topic><topic>Neurogtics</topic><topic>Neuromuscular diseases</topic><topic>Neuropathy</topic><topic>Panels</topic><topic>Paraplegics</topic><topic>Patients</topic><topic>Pedigree</topic><topic>Phenotype</topic><topic>Phenotypes</topic><topic>Retrospective Studies</topic><topic>sensory ataxia</topic><topic>Short Communication</topic><topic>spastic paraparesis</topic><topic>Spastic Paraplegia, Hereditary - genetics</topic><topic>Spasticity</topic><topic>Ubiquitin-Protein Ligases - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van Daele, Sien H.</creatorcontrib><creatorcontrib>Moisse, Matthieu</creatorcontrib><creatorcontrib>Race, Valérie</creatorcontrib><creatorcontrib>Van Eesbeeck, Amélie</creatorcontrib><creatorcontrib>Keldermans, Liesbeth</creatorcontrib><creatorcontrib>Vermeer, Sascha</creatorcontrib><creatorcontrib>Van Esch, Hilde</creatorcontrib><creatorcontrib>Claeys, Kristl G.</creatorcontrib><creatorcontrib>Van Damme, Philip</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van Daele, Sien H.</au><au>Moisse, Matthieu</au><au>Race, Valérie</au><au>Van Eesbeeck, Amélie</au><au>Keldermans, Liesbeth</au><au>Vermeer, Sascha</au><au>Van Esch, Hilde</au><au>Claeys, Kristl G.</au><au>Van Damme, Philip</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RNF170 mutation causes autosomal dominant sensory ataxia with variable pyramidal involvement</atitle><jtitle>European journal of neurology</jtitle><addtitle>Eur J Neurol</addtitle><date>2022-01</date><risdate>2022</risdate><volume>29</volume><issue>1</issue><spage>345</spage><epage>349</epage><pages>345-349</pages><issn>1351-5101</issn><eissn>1468-1331</eissn><abstract>Background
Although hereditary ataxias are a group of clinically and genetically heterogeneous disorders, specific clinical clues can sometimes incriminate certain genes. This can trigger genetic testing in sporadic patients or prompt dissecting certain genes more thoroughly when initial genetic testing is negative. Also for the assembly of gene panels and interpretation of the results, genotype−phenotype correlations remain important to establish.
Methods
We clinically evaluated a Belgian family with autosomal dominant inherited sensory ataxia and variable pyramidal involvement and performed targeted clinical exome sequencing. Secondly, we retrospectively screened sequencing data of an in‐house cohort of 404 patients with neuromuscular disorders for variants in the identified gene RNF170.
Results
All affected family members showed sensory ataxia on examination. Pyramidal involvement, and sometimes slow‐pursuit abnormalities and/or a sensory neuropathy, were more variable findings. We identified the heterozygous variant p.Arg199Cys in RNF170 in all three affected siblings of our family. We did not find additional pathogenic variants in RNF170 in our in‐house neuromuscular cohort.
Conclusions
We confirm the heterozygous variant p.Arg199Cys in RNF170 in a Belgian family with autosomal dominant sensory ataxia and variable pyramidal involvement. This constitutes a rare but clinically recognizable phenotype that warrants testing of RNF170. Unlike the distinctive bi‐allelic loss of function variants in RNF170 associated with hereditary spastic paraplegia (HSP), the p.Arg199Cys variant is the only one reported in sensory ataxia. It is important for neurologists to be aware of this characteristic phenotype and to include this gene in gene panels for ataxia and HSP.
Patients with the heterozygous variant p.Arg199Cys in RNF170 display a characteristic phenotype of autosomal dominant sensory ataxia with variable pyramidal involvement and sometimes slow‐pursuit abnormalities and/or a sensory neuropathy. Unlike the distinctive bi‐allelic loss of function variants in RNF170 associated with hereditary spastic paraplegia (HSP), the p.Arg199Cys variant is the only one reported in sensory ataxia. It is important for neurologists to be aware of this characteristic phenotype and to include this gene in gene panels for ataxia and HSP.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>34469621</pmid><doi>10.1111/ene.15091</doi><tpages>0</tpages><orcidid>https://orcid.org/0000-0002-3005-3619</orcidid><orcidid>https://orcid.org/0000-0002-4010-2357</orcidid><orcidid>https://orcid.org/0000-0001-9937-443X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1351-5101 |
ispartof | European journal of neurology, 2022-01, Vol.29 (1), p.345-349 |
issn | 1351-5101 1468-1331 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9290118 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Abnormalities Ataxia Ataxia - genetics case study Disorders Genes Genetic screening Genotype & phenotype Genotypes genotype−phenotype correlation Hereditary spastic paraplegia Humans medical genetics Mutation Mutation - genetics Neurogtics Neuromuscular diseases Neuropathy Panels Paraplegics Patients Pedigree Phenotype Phenotypes Retrospective Studies sensory ataxia Short Communication spastic paraparesis Spastic Paraplegia, Hereditary - genetics Spasticity Ubiquitin-Protein Ligases - genetics |
title | RNF170 mutation causes autosomal dominant sensory ataxia with variable pyramidal involvement |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T18%3A02%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RNF170%20mutation%20causes%20autosomal%20dominant%20sensory%20ataxia%20with%20variable%20pyramidal%20involvement&rft.jtitle=European%20journal%20of%20neurology&rft.au=Van%20Daele,%20Sien%20H.&rft.date=2022-01&rft.volume=29&rft.issue=1&rft.spage=345&rft.epage=349&rft.pages=345-349&rft.issn=1351-5101&rft.eissn=1468-1331&rft_id=info:doi/10.1111/ene.15091&rft_dat=%3Cproquest_pubme%3E2607544822%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2607544822&rft_id=info:pmid/34469621&rfr_iscdi=true |